SLC5A2 and hydrops fetalis: This review: (1) elaborates on the pathophysiology of exercise intolerance in HF; (2) discusses the potential modes of action of SGLT2 inhibitors on these phenomena; and (3) provides an up-to-date overview of the available studies on SGLT2 inhibitors and their effect on clinical outcome parameters, including physical functioning and exercise capacity.